AVY
74
2
SO
70
-3
PYPL
39
4
KHC
29
2
PNW
49
4
WHR
57
2
VFC
45
3
EQT
19
-5
NDAQ
48
3
AVB
72
3
K
30
-2
VMC
57
3
CTAS
64
2
PM
52
-4
TGNA
58
4
FOX
30
2
XYL
43
-4
HAS
49
3
BRK.B
42
2
HRL
29
2
AVY
74
2
SO
70
-3
PYPL
39
4
KHC
29
2
PNW
49
4
WHR
57
2
VFC
45
3
EQT
19
-5
NDAQ
48
3
AVB
72
3
K
30
-2
VMC
57
3
CTAS
64
2
PM
52
-4
TGNA
58
4
FOX
30
2
XYL
43
-4
HAS
49
3
BRK.B
42
2
HRL
29
2
Financhill
Back

Salesforce Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
59

CRM
Salesforce

Last Price:
244.90
Seasonality Move:
9.68%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
59
Salesforce (CRM) is a Buy

Is Salesforce a Buy, Sell or Hold?

  • The current Salesforce [CRM] share price is $245.06. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRM Stock Price Chart

What is Salesforce's stock price today?

  • The Salesforce share price today is $245.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRM is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.15 Sell
Relative Strength Index (14 RSI): 46.36 Sell
Chaikin Money Flow: 13615006 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (229.61 - 273.67) Sell
Bollinger Bands (100): (257.96 - 304.18) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 235.86 Buy
20-day SMA: 243.31 Buy
50-day SMA: 264.24 Sell
200-day SMA: 256.63 Sell
8-day EMA: 238.34 Buy
20-day EMA: 245.07 Sell
50-day EMA: 260.36 Sell
200-day EMA: 256.69 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Salesforce Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.21 per share, an increase this year of $3.27 per share, and an increase next year of $1.70 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Salesforce Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):